Osmotica Pharmaceuticals plc (OSMT) Receives FDA Approval for Upneeq, 0.1% for Acquired Blepharoptosis in Adults

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Osmotica Pharmaceuticals plc (OSMT) Receives FDA Approval for Upneeq, 0.1% for Acquired Blepharoptosis in Adults

Osmotica Pharmaceuticals plc (OSMT) Adds to Gains Following FDA Approval

July 10, 2020 11:25 AM EDT

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) sees continued momentum following FDA approval of Upneeq on Thursday; shares up 18%.

... More

Osmotica (OSMT) PT Raised to $12 at RBC Capital After Upneeq Approval

July 9, 2020 1:03 PM EDT

RBC Capital analyst Randall Stanicky raised the price target on Osmotica (NASDAQ: OSMT) to $12.00 (from $10.00) while maintaining an Outperform rating.

Upneeq approval sets up the next leg of "specialty" growth... More